+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Trends in epidemiology of hepatitis in the Israel Defense Forces



Trends in epidemiology of hepatitis in the Israel Defense Forces



Harefuah 138(9): 755-757, 804-805



During the 50's and 60's there were large scale epidemics of hepatitis A every 3-4 years in the Israel Defense Forces. During these epidemics the annual incidence exceeded 10/1000 soldiers at risk. There has been a highly significant decrease in rates during the past 30 years. The average annual incidence of clinically identified viral hepatitis A decreased from an average of 6/1000 during the 60's to 2.5/1000 during the 70's. The decrease coincide with the introduction in the 1970's of wide-scale post-exposure prophylaxis with immune serum globulin (ISG). The incidence was further significantly reduced to 0.5-1.0/1000 with the introduction of pre-exposure prophylaxis with ISG, starting in 1978 (p<0.001). Other factors probably played a role in accelerating the decline in morbidity, such as improvement in personal hygiene and sanitation facilities, and in waste disposal and other aspects of military environmental health. These improvements were probably more pronounced in the civilian sector, leading to decreased exposure of children to the virus and consequently a higher proportion of seronegatives at induction. Increase in the proportion of recruits without natural immunity to the virus poses greater risk, both in terms of personal morbidity as well as military operational ability. This risk, combined with problems of ISG use and availability, has propelled hepatitis A prevention policy towards the use of the new inactivated vaccines.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 011594476

Download citation: RISBibTeXText


Related references

Trends in epidemiology of hepatitis in the Israel Defense Forces-- direction over several years. Harefuah 138(9): 755, 2000

Epidemiology of gonorrhea among men in the Israel Defense Forces. Israel Journal of Medical Sciences 23(4): 249-251, 1987

The epidemiology of relapsing fever in the Israel Defense Forces, 1966--76. Harefuah 95(11): 367-370, 1978

Mortality epidemiology in low-intensity warfare: Israel Defense Forces' experience. Injury 32(1): 1-3, 2001

Hepatitis a antibody in israel defense forces recruits. Journal of Medical Virology 6(4): 341-346, 1980

Trends of stress fracture prevalence among Israel Defense Forces basic trainees. Military Medicine 176(1): 56-59, 2011

Acute non b hepatitis in the israel defense forces comparison of some epidemiologic features before and after the usage of preexposure immune serum globulin prophylaxis. Hepatology 7(6): 1330-1332, 1987

Pre exposure prophylaxis of viral hepatitis with immune serum globulin in a endemic area a trial in field units of the israel defense forces. Scandinavian Journal of Infectious Diseases 15(1): 3-6, 1983

Treatment Seeking for Posttraumatic Stress in Israel Defense Forces Veterans Deployed in the 2006 Israel-Hezbollah War: A 7-Year Post-War Follow-Up. Israel Journal of Psychiatry and Related Sciences 55(2): 4-9, 2018

Lessons from the Israel Defense Forces Medical Corps' Experience in the Organization of International Medical Disaster Relief Forces. Prehospital and Disaster Medicine 7(3): 282-284, 1992

Limiting out-of-hospital intubation in the Israel Defense Forces. Annals of Emergency Medicine 45(6): 677, 2005

Refractive surgery in Israel Defense Forces recruits. Journal of Cataract and Refractive Surgery 34(2): 243-246, 2008

A hearing survey in Israel defense forces inductees. Harefuah 83(4): 147-149, 1972

Poisonous animal bites in the Israel Defense Forces. Public Health Reviews 26(3): 237-245, 1998

Field treatment of snakebites in the Israel Defense Forces. Public Health Reviews 26(3): 247-256, 1998